Over the course of the past few weeks, all five of the large, publicly traded health plans have hosted their second set of earnings calls...

In the last couple of months, we’ve been pulling up chairs with dozens of revenue cycle leaders to understand what’s keeping them awake...

Welcome to our sneak peek into some of the major things we’re studying across the remainder of this year. Here, we’re about to break down...

Quick rewind: our tour of the clinical data market that ended in a cliffhanger In Part 1 of this blog post (linked below if you missed...

Health system leaders have long been interested in figuring out ways to monetize clinical data. It makes sense: if they could sell or license de-identified data in their EHRs to life science or tech companies, that would be very helpful from a revenue diversification perspective. Especially whenever core inpatient economics are under siege.  But, it’s always been an easier-said-than-done proposition. And now, maybe there's also a new spoiler in the mix, in the form of 'synthe

Later this week, we'll be convening live for this month's Board Briefing webinar to talk about the current state of the physician...

Time to separate the settled from the volatile issues in risk/VBC politics today With so much policy upheaval these days, it can be easy...

If your go-to mental model for risk/VBC revolves around primary care management of chronic conditions, it's time for a conceptual...

Last week, we published an update on the Make America Healthy Again initiative: what its agenda looks like as of April 2025 and how the...

Back in December, we conducted something of a thought experiment. At the time, then-nominee Robert F. Kennedy, Jr.'s "Make America...

At the beginning of each year, we like to do a deep dive into the healthcare investment landscape. We do a retrospective on the previous...

This month's Union Strategy Bootcamp, “How to Speak Ambulatory" is set to cover all the essentials : Key concepts, players,...